Moreover, the vaccine investigated in this study could be supplemented in the future with an additional viral construct expressing proinsulin (rVV-CTB::INS), which we demonstrated earlier to provide dramatic suppression of new diabetes onset in NOD mice [9]. Here, INS is linked to diabetes mellitus.